⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
AlphaSense Announces AlphaSummit 2026 to Explore the Future of Decision-Grade AI
globenewswire.com
GS
JNJ
CRM
MRK
BioInvent Publication in JECCR: Tailored FcγR Blockade with BI-1206 and BI-1607 Enhances Cancer Antibody Therapies and Overcomes Resistance in Preclinical Models
accessnewswire.com
MRK
Necrotizing Enterocolitis Market to Register Stunning Growth at a CAGR of 26% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
JAGX
MRK
CASI
JAZZ
Mana.bio Announces the Appointment of Laura Sepp-Lorenzino to its Scientific Advisory Board
prnewswire.com
NTLA
VRTX
ALNY
MRK
TGTX
LXEO
Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights
globenewswire.com
MRK
BMY
Par Health Launches First and Only Generic Version of Janumet® XR (sitagliptin and metformin HCl extended-release) Tablets in the United States
prnewswire.com
PRPH
MRK
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
businesswire.com
MRK
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
prnewswire.com
REGN
MRK
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX